- Shams P, Ahmed I. Cardiac amyloidosis. In: StatPearls. Treasure Island, FL: StatPearls Publishing; 2023.
- Jaiswal V, Agrawal V, Khulbe Y, et al. Cardiac amyloidosis and aortic stenosis: a state-of-the-art review. Eur Heart J Open. 2023;3(6):oead106. doi:10.1093/ehjopen/oead106.
- Balciunaite G, Rimkus A, Zurauskas E, et al. Transthyretin cardiac amyloidosis in aortic stenosis: prevalence, diagnostic challenges, and clinical implications. Hellenic J Cardiol. 2020;61(2):92–98. doi:10.1016/j.hjc.2019.10.004.
- Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev. 2021;10(1):89. doi:10.1186/s13643-021-01626-4.
- Hoerbrand IA, Volz MJ, Aus Dem Siepen F, et al. Initial experience with transcatheter tricuspid valve repair in patients with cardiac amyloidosis. ESC Heart Fail. 2022;10(2):1003–1012. doi:10.1002/ehf2.14262.
- Ullah W, Ruge M, Hajduczok A, et al. Adverse outcomes of atrial fibrillation ablation in heart failure patients with and without cardiac amyloidosis: a nationwide readmissions database analysis (2015–2019). Eur Heart J Open. 2023;3(2):oead026. doi:10.1093/ehjopen/oead026.
- Giancaterino S, Urey MA, Darden D, Hsu JC. Management of arrhythmias in cardiac amyloidosis. JACC Clin Electrophysiol. 2020;6(4):351–361. doi:10.1016/j.jacep.2020.01.004.
Baylor University Medical Center Proceedings
The peer-reviewed journal of Baylor Scott & White Health
Volume 37, 2024 - Issue 4
Brief Research Reports
Outcomes of transcatheter aortic valve replacement in patients with amyloidosis: a comparative meta-analysis
Hasaan Ahmeda Department of Medicine, Division of Internal Medicine, Creighton University School of Medicine, Omaha, Nebraska, USACorrespondence[email protected]
https://orcid.org/0009-0004-7825-8252
, MDhttps://orcid.org/0009-0004-7825-8252, , MD, , MD, , MD, , MD, , MD, , MD, MS, , MD & , MD show all